Gene · 9112
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Role of Leptin and Adiponectin in Carcinogenesis. | Cancers (Basel) | 2023 | 37686525 | PubTator, text mining | PubMed |
| Impact of Age at Diagnosis on Clinicopathological Features, Prognosis, and Management of Gastric Cancer: A Retrospective Single-Center Experience from Spain. | Cancers (Basel) | 2023 | 37686517 | PubTator, text mining | PubMed |
| JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. | Cancer Commun (Lond) | 2023 | 37658635 | PubTator, text mining | PubMed |
| Resveratrol and Other Natural Oligomeric Stilbenoid Compounds and Their Therapeutic Applications. | Plants (Basel) | 2023 | 37631147 | PubTator, text mining | PubMed |
| Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. | Cancers (Basel) | 2023 | 37627209 | PubTator, text mining | PubMed |
| The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach. | Cancers (Basel) | 2023 | 37627055 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
| MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. | Cancer Cell Int | 2023 | 37587481 | PubTator, text mining | PubMed |
| Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. | Cell Biosci | 2023 | 37580808 | PubTator, text mining | PubMed |
| HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation. | Cell Discov | 2023 | 37580347 | PubTator, text mining | PubMed |
| Regulation of DNA damage and transcriptional output in the vasculature through a cytoglobin-HMGB2 axis. | Redox Biol | 2023 | 37573836 | PubTator, text mining | PubMed |
| Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response. | Cancers (Basel) | 2023 | 37568822 | PubTator, text mining | PubMed |
| Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies. | Glob Med Genet | 2023 | 37565061 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| Hepatitis C virus non-structural proteins modulate cellular kinases for increased cytoplasmic abundance of host factor HuR and facilitate viral replication. | PLoS Pathog | 2023 | 37540723 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer. | Elife | 2023 | 37530744 | PubTator, text mining | PubMed |
| Transposable Elements: Epigenetic Silencing Mechanisms or Modulating Tools for Vertebrate Adaptations? Two Sides of the Same Coin. | Int J Mol Sci | 2023 | 37511347 | PubTator, text mining | PubMed |
| The Role of ARHGAP1 in Rho GTPase Inactivation during Metastasizing of Breast Cancer Cell Line MCF-7 after Treatment with Doxorubicin. | Int J Mol Sci | 2023 | 37511111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9112/papers?page=7